Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

164 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Oral Inflammation and Microbiome Dysbiosis Exacerbate Chronic Graft-versus-host Disease.
Kambara Y, Fujiwara H, Yamamoto A, Gotoh K, Tsuji S, Kunihiro M, Oyama T, Terao T, Sato A, Tanaka T, Peltier D, Seike K, Nishimori H, Asada N, Ennishi D, Fujii K, Fujii N, Matsuoka KI, Soga Y, Reddy P, Maeda Y. Kambara Y, et al. Among authors: matsuoka ki. Blood. 2024 Dec 18:blood.2024024540. doi: 10.1182/blood.2024024540. Online ahead of print. Blood. 2024. PMID: 39693612
Association between early anti-cytomegalovirus therapy and the incidence of chronic graft-versus-host disease.
Miyao K, Murata M, Nishida T, Ozawa Y, Uchida N, Fukuda T, Doki N, Eto T, Kawakita T, Mori Y, Takada S, Ohigashi H, Tanaka M, Kanda Y, Matsuoka KI, Ishimaru F, Atsuta Y, Kanda J, Terakura S; GVHD Working Group of the Japanese Society for Transplantation and Cellular Therapy. Miyao K, et al. Among authors: matsuoka ki. Int J Hematol. 2024 Nov 14. doi: 10.1007/s12185-024-03871-4. Online ahead of print. Int J Hematol. 2024. PMID: 39543007
Outcome of donor lymphocyte infusion after allogeneic hematopoietic stem cell transplantation in relapsed myelodysplastic syndrome.
Marumo A, Nagata Y, Fujioka M, Kurosawa S, Najima Y, Sakaida E, Doki N, Fukushima K, Ota S, Shono K, Ito A, Uchida N, Nishida T, Sawa M, Tsunemine H, Matsuoka KI, Makoto O, Kanda Y, Fukuda T, Atsuta Y, Itonaga H. Marumo A, et al. Among authors: matsuoka ki. Cytotherapy. 2024 Oct 17:S1465-3249(24)00884-3. doi: 10.1016/j.jcyt.2024.09.006. Online ahead of print. Cytotherapy. 2024. PMID: 39503682
Female-to-male allogeneic transplantation affects outcomes differently according to the type of haplo-transplantation.
Tamaki M, Kawamura S, Takano K, Nakamae H, Doki N, Ohigashi H, Maruyama Y, Ota S, Hiramoto N, Eto T, Yoshihara S, Matsuoka KI, Masuko M, Onizuka M, Kanda Y, Fukuda T, Atsuta Y, Yanagisawa R, Yakushijin K, Nakasone H. Tamaki M, et al. Among authors: matsuoka ki. Cytotherapy. 2024 Oct 5:S1465-3249(24)00886-7. doi: 10.1016/j.jcyt.2024.09.007. Online ahead of print. Cytotherapy. 2024. PMID: 39453336
Comparison of HLA-haploidentical donors with post-transplant cyclophosphamide versus HLA-matched unrelated donors in peripheral blood stem cell transplantation for acute myeloid leukaemia.
Moriguchi M, Nakamae H, Nishimoto M, Sugita J, Yanada M, Toubai T, Hasegawa Y, Hino M, Nishida T, Kurita N, Sawa M, Fukuda T, Jinguji A, Ota S, Matsuoka KI, Eto T, Hiramoto N, Ando T, Kawamura K, Kanda Y, Atsuta Y, Ohbiki M, Nakasone H, Konuma T. Moriguchi M, et al. Among authors: matsuoka ki. Br J Haematol. 2024 Dec;205(6):2376-2386. doi: 10.1111/bjh.19825. Epub 2024 Oct 22. Br J Haematol. 2024. PMID: 39439234
Superior Survival After Unrelated Allogeneic Stem Cell Transplantation With Low-Dose ATG Compared to Low-Dose TBI in Myeloablative Fludarabine/Busulfan-Based Regimen for MDS on Behalf of the Adult MDS Working Group of the JSTCT.
Fujioka M, Itonaga H, Nakazawa H, Nishida T, Kataoka K, Ikeda T, Kako S, Matsuoka KI, Adachi K, Fujiwara SI, Aotsuka N, Kawakita T, Sakaida E, Kanda Y, Ichinohe T, Atsuta Y, Miyazaki Y, Ishiyama K. Fujioka M, et al. Among authors: matsuoka ki. Transplant Cell Ther. 2024 Oct 6:S2666-6367(24)00693-6. doi: 10.1016/j.jtct.2024.09.026. Online ahead of print. Transplant Cell Ther. 2024. PMID: 39374663
Combination of reduced post-transplant cyclophosphamide and early tacrolimus initiation increases the incidence of chronic graft-versus-host disease in human leukocyte antigen-haploidentical peripheral blood stem-cell transplantation.
Terao T, Kondo T, Nakamura M, Takasuka H, Fujiwara H, Asada N, Ennishi D, Nishimori H, Fujii K, Fujii N, Maeda Y, Matsuoka KI. Terao T, et al. Among authors: matsuoka ki. EJHaem. 2024 Jun 19;5(4):810-814. doi: 10.1002/jha2.962. eCollection 2024 Aug. EJHaem. 2024. PMID: 39157621 Free PMC article.
164 results